Neumora Therapeutics
NMRA
NMRA
93 hedge funds and large institutions have $92.3M invested in Neumora Therapeutics in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 40 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
5% less funds holding
Funds holding: 98 → 93 (-5)
28% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 18
60% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 40
Holders
93
Holding in Top 10
1
Calls
$600K
Puts
$183K
Top Buyers
| 1 | +$1.51M | |
| 2 | +$1.41M | |
| 3 | +$548K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$279K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$214K |
Top Sellers
| 1 | -$1.94M | |
| 2 | -$1.45M | |
| 3 | -$1.3M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.03M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$949K |
